Investigation of the Effects of Eugenol and Quercetin on Bone Loss in STZ-NA Induced Diabetic Rats Utilizing Micro CT

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2022 Jun 8

PMID 35673437

Authors

Aycan Bas

Isil Albeniz

Affiliations

Soon will be listed here.

Abstract

Purpose: Diabetes Mellitus (DM) is a systemic disease that can effect tissues and their physiological functions at molecular and biochemical levels. Diabetic osteoporosis is one of the chronic diseases of bone metabolism effected by and characterized by augmented risk of osteoporotic fractures and destroying of bone microarchitecture. It was aimed to investigate the alterations in femoral bone structure that may take place as a complication of DM by using the antioxidant properties of eugenol and quercetin, which are phenolic compounds, in streptozotocin nicotinamide (STZ-NA) induced rats as an experimental type 2 DM (T2 DM) model.

Methods: The antioxidant effect of eugenol and quercetin in case of DM development was determined by GSH ELISA kit. The effect of DM on alterations in bone structure was analyzed by micro CT. BMD, Tb.Bv/Tb.Tv, Tb.N, Tb.Th, Ct.Th, Tb.Sp and SMI data were calculated with the software CTAn.

Results: Serum GSH levels, Tb.Th and Tb.Bv/Tb.Tv values statistically decreased, and SMI values statistically increased in diabetic group compared with controls. Serum GSH levels in eugenol group were higher than diabetic group, and Tb.Bv/Tb.Tv values in eugenol group were lower than controls. Quercetin group had higher serum GSH levels and Tb.Th values compared with diabetic group, while SMI values were lower in quercetin group compared with diabetic group.

Conclusion: Eugenol and quercetin were revealed to have antioxidant, antidiabetic and osteoprotective effects on the repair of bone structure in experimental STZ-NA T2 DM model.

Citing Articles

Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway.

Lei S, Wang Y, Huang X, Wang X, Gao M, Li B Mol Med. 2025; 31(1):101.

PMID: 40089686 DOI: 10.1186/s10020-025-01152-2.

Impact of different 3D regions of interest on quantifying dynamic lumbar vertebral microstructure in ovariectomized rats-a micro-CT study.

Xu H, Liu H, Liu M, Li Y, Pan J, Wang S Front Med (Lausanne). 2025; 11:1503761.

PMID: 40034239 PMC: 11873078. DOI: 10.3389/fmed.2024.1503761.

Role of oxidative stress in impaired type II diabetic bone repair: scope for antioxidant therapy intervention?.

Li P, Alenazi K, Dally J, Woods E, Waddington R, Moseley R Front Dent Med. 2025; 5:1464009.

PMID: 39917650 PMC: 11797775. DOI: 10.3389/fdmed.2024.1464009.

Bioactive Compounds from Propolis on Bone Homeostasis: A Narrative Review.

Bertolucci V, Ninomiya A, Longato G, Kaneko L, Nonose N, Scariot P Antioxidants (Basel). 2025; 14(1).

PMID: 39857415 PMC: 11762496. DOI: 10.3390/antiox14010081.

Pharmacological and mechanistic aspects of quercetin in osteoporosis.

Deng T, Ding W, Lu X, Zhang Q, Du J, Wang L Front Pharmacol. 2024; 15:1338951.

PMID: 38333006 PMC: 10851760. DOI: 10.3389/fphar.2024.1338951.

References

Zeitoun D, Caliaperoumal G, Bensidhoum M, Constans J, Anagnostou F, Bousson V . Microcomputed tomography of the femur of diabetic rats: alterations of trabecular and cortical bone microarchitecture and vasculature-a feasibility study. Eur Radiol Exp. 2019; 3(1):17. PMC: 6458201. DOI: 10.1186/s41747-019-0094-5. View

Coskun O, Kanter M, Korkmaz A, Oter S . Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res. 2005; 51(2):117-23. DOI: 10.1016/j.phrs.2004.06.002. View

Hua Y, Bi R, Li Z, Li Y . Resveratrol treatment promotes titanium implant osseointegration in diabetes mellitus rats. J Orthop Res. 2020; 38(10):2113-2119. DOI: 10.1002/jor.24651. View

Abuohashish H, Khairy D, Abdelsalam M, Alsayyah A, Ahmed M, Al-Rejaie S . In-vivo assessment of the osteo-protective effects of eugenol in alveolar bone tissues. Biomed Pharmacother. 2017; 97:1303-1310. DOI: 10.1016/j.biopha.2017.11.068. View

Liang W, Luo Z, Ge S, Li M, Du J, Yang M . Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia. Eur J Pharmacol. 2011; 670(1):317-24. DOI: 10.1016/j.ejphar.2011.08.014. View

Vianna A, Sanches C, Barreto F . Review article: effects of type 2 diabetes therapies on bone metabolism. Diabetol Metab Syndr. 2017; 9:75. PMC: 5613523. DOI: 10.1186/s13098-017-0274-5. View

Niu Y, Yang Y, Xiao X, Sun Y, Zhou Y, Zhang Y . Quercetin prevents bone loss in hindlimb suspension mice via stanniocalcin 1-mediated inhibition of osteoclastogenesis. Acta Pharmacol Sin. 2020; 41(11):1476-1486. PMC: 7656592. DOI: 10.1038/s41401-020-00509-z. View

Huang Y, Wang Z, Deng L, Wang H, Zheng Q . Oral Administration of Quercetin or Its Derivatives Inhibit Bone Loss in Animal Model of Osteoporosis. Oxid Med Cell Longev. 2020; 2020:6080597. PMC: 7641676. DOI: 10.1155/2020/6080597. View

Jeong K, Kim D, Quan H, Jo H, Kim G, Chung S . Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice. Fitoterapia. 2014; 93:150-62. DOI: 10.1016/j.fitote.2013.12.023. View

10.

Nyman J, Even J, Jo C, Herbert E, Murry M, Cockrell G . Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone. 2010; 48(4):733-40. PMC: 3062641. DOI: 10.1016/j.bone.2010.12.016. View

11.

Kawashima Y, Fritton J, Yakar S, Epstein S, Schaffler M, Jepsen K . Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis. Bone. 2009; 44(4):648-55. PMC: 2659558. DOI: 10.1016/j.bone.2008.12.012. View

12.

Dokumacioglu E, Iskender H, Sen T, Ince I, Dokumacioglu A, Kanbay Y . The Effects of Hesperidin and Quercetin on Serum Tumor Necrosis Factor-Alpha and Interleukin-6 Levels in Streptozotocin-induced Diabetes Model. Pharmacogn Mag. 2018; 14(54):167-173. PMC: 5909310. DOI: 10.4103/pm.pm_41_17. View

13.

Szkudelski T . Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp Biol Med (Maywood). 2012; 237(5):481-90. DOI: 10.1258/ebm.2012.011372. View

14.

Glorie L, Behets G, Baerts L, De Meester I, DHaese P, Verhulst A . DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats. Am J Physiol Endocrinol Metab. 2014; 307(5):E447-55. DOI: 10.1152/ajpendo.00217.2014. View

15.

Dias A, Porawski M, Alonso M, Marroni N, Collado P, Gonzalez-Gallego J . Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr. 2005; 135(10):2299-304. DOI: 10.1093/jn/135.10.2299. View

16.

Schwartz A . Diabetes Mellitus: Does it Affect Bone?. Calcif Tissue Int. 2003; 73(6):515-9. DOI: 10.1007/s00223-003-0023-7. View

17.

Eid H, Nachar A, Thong F, Sweeney G, Haddad P . The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacogn Mag. 2015; 11(41):74-81. PMC: 4329636. DOI: 10.4103/0973-1296.149708. View

18.

Pereira M, Gohin S, Lund N, Hvid A, Smitham P, Oddy M . Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus. Osteoporos Int. 2016; 28(1):309-320. PMC: 5206261. DOI: 10.1007/s00198-016-3718-0. View

19.

Al-Trad B, AlKhateeb H, Alsmadi W, Al-Zoubi M . Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat-diet/streptozotocin-induced diabetic rat. Life Sci. 2018; 216:183-188. DOI: 10.1016/j.lfs.2018.11.034. View

20.

Sanae F, Kamiyama O, Ikeda-Obatake K, Higashi Y, Asano N, Adachi I . Effects of eugenol-reduced clove extract on glycogen phosphorylase b and the development of diabetes in db/db mice. Food Funct. 2013; 5(2):214-9. DOI: 10.1039/c3fo60514k. View